BTK Inhibitors as Sensitizing Agents in Solid Tumors
Robert Dreicer, Varinder Kaur, Al-Ola A. Abdallah
1 892 kr
AvRamasamy Paulmurugan,Tarik F. Massoud
Del 15 i serien Cancer Sensitizing Agents for Chemotherapy
1 728 kr
Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt över 249 kr.
Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies brings current knowledge from an international team of experts on the science and clinical management of glioblastoma chemoresistance. The book discusses topics such as molecular mechanisms of chemoresistance, experimental models to study chemoresistance, chemoresistance to drugs other than Temozolomide, and specific strategies to reverse chemoresistance. Additionally, it encompasses information on how to mitigate chemoresistance by targeted enhancement of p53 function. This book is a valuable resource for cancer researchers, oncologists, neuro-oncologists and other members of the biomedical field.
Glioblastoma (GBM) is the most invasive and malignant primary brain tumor in humans with poor survival after diagnosis, therefore it is imperative that molecular and cellular mechanisms behind therapy resistant GBM cells, as well as the therapeutic strategies available to counter the resistance are comprehensively understood.